PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

2021 BMJ 9,430 citations

Abstract

The methods and results of systematic reviews should be reported in sufficient detail to allow users to assess the trustworthiness and applicability of the review findings. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement was developed to facilitate transparent and complete reporting of systematic reviews and has been updated (to PRISMA 2020) to reflect recent advances in systematic review methodology and terminology. Here, we present the explanation and elaboration paper for PRISMA 2020, where we explain why reporting of each item is recommended, present bullet points that detail the reporting recommendations, and present examples from published reviews. We hope that changes to the content and structure of PRISMA 2020 will facilitate uptake of the guideline and lead to more transparent, complete, and accurate reporting of systematic reviews.

Keywords

Systematic reviewTerminologyGuidelineComputer scienceMEDLINEData scienceMedicineManagement sciencePathologyPolitical science

MeSH Terms

Data AccuracyEvidence-Based MedicineHumansMedical WritingMeta-Analysis as TopicPractice Guidelines as TopicQuality ControlResearch DesignStatistics as TopicSystematic Reviews as TopicTerminology as Topic

Affiliated Institutions

Related Publications

Publication Info

Year
2021
Type
article
Volume
372
Pages
n160-n160
Citations
9430
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

9430
OpenAlex
252
Influential
7084
CrossRef

Cite This

Matthew J. Page, David Moher, Patrick M. Bossuyt et al. (2021). PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ , 372 , n160-n160. https://doi.org/10.1136/bmj.n160

Identifiers

DOI
10.1136/bmj.n160
PMID
33781993
PMCID
PMC8005925

Data Quality

Data completeness: 86%